Mpox vaccine maker seeks approval for use in teens

By Agence France-Presse

Aug 16, 2024 6:08 pm

COPENHAGEN, Denmark — Danish drugmaker Bavarian Nordic said Friday it was seeking European approval to use its mpox vaccine in children aged 12 to 17, after the WHO declared the current virus surge a global public health emergency.

The World Health Organization (WHO) this week declared the rapid spread of the new, more dangerous mpox strain, dubbed Clade 1b, a public health emergency of international concern -- the highest alarm the UN agency can sound.

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

Yoon's impeachment brings joy, relief

US, China renew scientific cooperation deal

Thai police detain two after festival bomb blast

Indian actor freed on bail after deadly stampede

Malaysian veteran dives for sunken golf treasure

Jordan hosts Syria talks after Damascus rejoices

France's Macron names centrist ally Bayrou as PM